Daniel N. Swisher, Jr

2012 - Sunesis Pharmaceuticals

In 2012, Daniel N. Swisher, Jr earned a total compensation of $1.2M as CEO and President at Sunesis Pharmaceuticals, a 31% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$217,000
Option Awards$522,198
Salary$431,894
Other$3,130
Total$1,174,222

Swisher received $522.2K in option awards, accounting for 44% of the total pay in 2012.

Swisher also received $217K in non-equity incentive plan, $431.9K in salary and $3.1K in other compensation.

Rankings

In 2012, Daniel N. Swisher, Jr's compensation ranked 5,507th out of 11,487 executives tracked by ExecPay. In other words, Swisher earned more than 52.1% of executives.

ClassificationRankingPercentile
All
5,507
out of 11,487
52nd
Division
Manufacturing
1,941
out of 4,253
54th
Major group
Chemicals And Allied Products
470
out of 1,203
61st
Industry group
Drugs
312
out of 925
66th
Industry
Pharmaceutical Preparations
242
out of 700
65th
Source: SEC filing on April 25, 2013.

Swisher's colleagues

We found three more compensation records of executives who worked with Daniel N. Swisher, Jr at Sunesis Pharmaceuticals in 2012.

2012

Adam Craig

Sunesis Pharmaceuticals

Chief Medical Officer

2012

Eric Bjerkholt

Sunesis Pharmaceuticals

Chief Financial Officer

2012

Steven Ketchum

Sunesis Pharmaceuticals

Former Senior Vice President, Research and Development

News

You may also like